TDLN-sparing RT Plus Immunotherapy and Chemotherapy in Locally Advanced ESCC

Clinical trial NCT06676449 · RECRUITING

Trial details

NCT number: NCT06676449
Sponsor: Fudan University
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Esophageal Carcinoma Radiotherapy Immunotherapy

Start date: 2024-11-01
Primary completion: 2028-10-31
Enrollment: 432

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.